Education
About Us
Working with TipRanks
Follow Us
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
RXRX Analyst Ratings
Hold
1 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
RXRX Stock 12 Month Forecast
Average Price Target
$6.25
▼(-2.80%Downside)
| Highest Price Target$8.00 | Average Price Target$6.25 | Lowest Price Target$4.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$7
Hold
8.86%
Upside
Reiterated
07/22/25
Recursion Pharmaceuticals' stock score is primarily influenced by technical analysis indicating strong upward momentum, offset by financial performance challenges and valuation concerns. Strategic partnerships and pipeline advancements are promising, but profitability and cash flow issues, along with a workforce reduction strategy, highlight significant risks.
Needham
$8
Buy
24.42%
Upside
Reiterated
07/08/25
Morgan Stanley
$5
Hold
-22.24%
Downside
Initiated
07/02/25
Leerink Partners
$3→$4
Hold
-37.79%
Downside
Reiterated
06/12/25
Bank of America Securities
$8
Hold
24.42%
Upside
Reiterated
06/10/25
TD Cowen
―
Hold
―
Reiterated
05/05/25
Unknown AnalystJ.P. Morgan
Not Ranked
J.P. Morgan
―
Hold
―
Reiterated
01/13/25
KeyBanc
$12→$10
Buy
55.52%
Upside
Reiterated
01/08/25
Jefferies
$8→$6
Hold
-6.69%
Downside
Reiterated
09/03/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$7
Hold
8.86%
Upside
Reiterated
07/22/25
Recursion Pharmaceuticals' stock score is primarily influenced by technical analysis indicating strong upward momentum, offset by financial performance challenges and valuation concerns. Strategic partnerships and pipeline advancements are promising, but profitability and cash flow issues, along with a workforce reduction strategy, highlight significant risks.
Needham
$8
Buy
24.42%
Upside
Reiterated
07/08/25
Morgan Stanley
$5
Hold
-22.24%
Downside
Initiated
07/02/25
Leerink Partners
$3→$4
Hold
-37.79%
Downside
Reiterated
06/12/25
Bank of America Securities
$8
Hold
24.42%
Upside
Reiterated
06/10/25
TD Cowen
―
Hold
―
Reiterated
05/05/25
Unknown AnalystJ.P. Morgan
Not Ranked
J.P. Morgan
―
Hold
―
Reiterated
01/13/25
KeyBanc
$12→$10
Buy
55.52%
Upside
Reiterated
01/08/25
Jefferies
$8→$6
Hold
-6.69%
Downside
Reiterated
09/03/24
Best Analysts Covering Recursion Pharmaceuticals
1 Month
xxx
Success Rate
8/19 ratings generated profit
Average Return
+2.00%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 42.11% of your transactions generating a profit, with an average return of +2.00% per trade.
3 Months
xxx
Success Rate
10/19 ratings generated profit
Average Return
+10.45%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 52.63% of your transactions generating a profit, with an average return of +10.45% per trade.
1 Year
2 Years
xxx
Success Rate
6/19 ratings generated profit
Average Return
-10.37%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 31.58% of your transactions generating a profit, with an average return of -10.37% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
RXRX Analyst Recommendation Trends
Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
1
2
2
2
1
Buy
2
1
0
0
1
Hold
7
6
8
14
18
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
9
10
16
20
Each month's total comprises the sum of three months' worth of ratings.
RXRX Financial Forecast
RXRX Stock Forecast FAQ
What is RXRX’s average 12-month price target, according to analysts?
Based on analyst ratings, Recursion Pharmaceuticals’s 12-month average price target is 6.25.
What is RXRX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for RXRX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RXRX a Buy, Sell or Hold?
Recursion Pharmaceuticals has a consensus rating of Hold which is based on 1 buy ratings, 4 hold ratings and 0 sell ratings.
What is Recursion Pharmaceuticals’s price target?
The average price target for Recursion Pharmaceuticals is 6.25. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $8.00 ,the lowest forecast is $4.00. The average price target represents -2.80% Decrease from the current price of $6.43.
The highest analyst price target is $8.00 ,the lowest forecast is $4.00. The average price target represents -2.80% Decrease from the current price of $6.43.
What do analysts say about Recursion Pharmaceuticals?
Recursion Pharmaceuticals’s analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of RXRX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.